Sparks commentary - The Platform Group

Consumer

Sparks - The Platform Group

More on this equity
The Platform Group (FRA: TPG) M&A leads to upgrade to FY26 revenue guidance
Published by Russell Pointon

Ahead of an investor presentation in Frankfurt today, management has increased its guidance for FY26 following acquisitions/agreements to acquire three companies in the pharmaceutical sector and two in the optics and hearing segment.

Management is now guiding to gross merchandise volume of €1.7bn (€1.6bn previously), revenue of €1bn (€860m previously) and adjusted EBITDA of €70-80m, ie a margin of 7-8% (margin of 7.5-10% previously or adjusted EBITDA of €64.5-86m).

The new figures represent y-o-y growth from the current unchanged FY25 guidance for revenue of 36-40% and adjusted EBITDA of c 30-38%.

 

Latest

Healthcare | Comment

Herantis Pharma (HEL: HRTIS) – a step closer to Phase II

Investment Companies | Comment

The Biotech Growth Trust (BIOG) reported encouraging H126 results

TMT | Comment

Nanoco (LSE:NANO) settles LG litigation for $5m

Healthcare | Comment

Mendus (OMX: IMMU) announces c SEK50m directed share issue